Submission Details

Submitter:

Classification:
Definitive
GENCC:100001
Gene:
Disease:
mosaic variegated aneuploidy syndrome 2
Mode Of Inheritance:
Autosomal recessive
Evaluated Date:
11/22/2019
Evidence/Notes:

Centrosomal protein 57kDa, also known as Translokin or TLk, encoded by CEP57 gene functions in microtubular stabilization and mediates its nuclear translocation and mitogenic activity. Mutations in this gene have been found to cause mosaic variegated aneuploidy (MVA) syndrome type 2. Snape K et al., (2011) using exome sequencing identified biallelic LoF CEP57 mutation as a cause of constitutional mosaic aneuploidies. In this article, two Mexican siblings with MVA carry the same compound heterozygous CEP57 mutations, a 2-bp deletion (520delGA) in exon 5, and an 11-bp duplication in exon 9 (915_925dup11); Another 2 individuals with biallelic CEP57 mutations, homozygous for c.341C>T;p.R81X, and c.915_925dup11, from a cohort of 13 BUB1B negative families with MVA were also identified. De La Torre-Garcia et al., (2018) identified a Mexico boy with MVA homozygous for CEP57 c.915_925dup11. Pinson L et al., (2014) found a Morocan girl from a consanguineous family homozygous for CEP57 c.915_925dup11. Brightman DS et al.(2018) found a Pakistani girl with MVA of a consanguineous family homozygous for CEP57 c.697delA, p.Lys235Argfs*31). Experimental evidences showed CEP57 protein is localized to kinetochore contributing spindle microtubule organization, CEP57 depletion leads to missegregation of chromosome. siRNA resistant Cep57 wt with mutated siRNA targeted region in HeLa cells rescued the phenotypes. Research on CEP57 gene function in microtubule stability has been upheld over time. In summary, there have been sufficient evidences supporting the association of CEP57 with autosomal recessive inherited Mosaic Variegated Aneuploidy (MVA) type 2.

PubMed IDs:
14654843 17803911 21552266 22508265 23569207 24259107 26743940 30010053 30035751 30147898
Public Report:
Assertion Criteria:
Submitter Submitted Date:
12/05/2025

The GenCC data are available free of restriction under a CC0 1.0 Universal (CC0 1.0) Public Domain Dedication. The GenCC requests that you give attribution to GenCC and the contributing sources whenever possible and appropriate. The accepted Flagship manuscript is now available from Genetics in Medicine (https://www.gimjournal.org/article/S1098-3600(22)00746-8/fulltext).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. The GenCC does not independently verify the submitted information. Though the information is obtained from sources believed to be reliable, no warranty, expressed or implied, is made regarding accuracy, adequacy, completeness, reliability or usefulness of any information. This disclaimer applies to both isolated and aggregate uses of the information. The information is provided on an "as is" basis, collected through periodic submission and therefore may not represent the most up-to-date information from the submitters. If you have questions about the medical relevance of information contained on this website, please see a healthcare professional; if you have questions about specific gene-disease claims, please contact the relevant sources; and if you have questions about the representation of the data on this website, please contact gencc@thegencc.org.